Article
Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP.
Cancer biology & medicine - 23 Nov 2021
Qin Yan, Chen Haizhu, Liu Peng, Zhang Changgong, Yang Jianliang, Gui Lin, He Xiaohui, Zhou Liqiang, Zhou Shengyu, Jiang Shiyu, Jiang Hongxin, Shi Yuankai
Abstract excerpt
OBJECTIVE: Limited data about the prognostic significance of BCL2 mutations and BCL2 copy number variations in diffuse large B-cell lymphoma (DLBCL) are available. This study aimed to comprehensively describe BCL2 genetic alterations in DLBCL patients, and examine correlation of BCL2, TP53 and other genetic alterations with outcomes in patients treated with R-CHOP. METHODS: Probe capture-based high-resolution...
Topics
- Adenosine Monophosphate
- Antineoplastic Combined Chemotherapy Protocols
- Cyclophosphamide
- DNA Copy Number Variations
- Doxorubicin
- Humans
- Lymphoma, Large B-Cell, Diffuse
- Mutation
- Prednisone
- Prognosis
- Proto-Oncogene Proteins c-bcl-2
- Proto-Oncogene Proteins c-myc
